AI-TOP Study Artificial Intelligence for Trigger Optimization.
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-42
SponsorFundacion Dexeus
About this trial
To evaluate, in a randomized controlled trial, whether AI-guided monitoring and ovulation triggering leads to clinical outcomes comparable to those achieved through physician-led decision-making in patients undergoing ovarian stimulation for IVF.
Eligibility criteria
Qualifiers
Undergoing COS for IVF with autologous oocytes, oocyte donation and elective fertility preservation with all monitoring USS (ultrasound scan) conducted at our centers.
Disqualifiers
Medically indicated fertility preservation
Inability to attend clinic visits for monitoring.
Trial design
Treatments tested in this trial
- STIMAI®.
- Routine clinical management
Treatment groups
644 Participants
are divided into 2 treatment groupsLocations
5Dexeus Mujer Sabadell SabadellBarcelona, Spain
Dexeus Mujer Sant Cugat08195, Sant Cugat del VallèsBarcelona, Spain
Dexeus Mujer Reus43202, ReusTarragona, Spain
Hospital Universitario Quiron Dexeus08028, Barcelona Spain
Sponsors and collaborators
Fundacion Dexeus
Lead sponsor
Source ClinicalTrials.gov